I'm curious if IV Vancomycin would generally be classified under "Drug therapy requiring intensive monitoring for toxicity" in the table of risk? From what I've read in trying to do some research, trough levels are monitored for concentration of the drug in the patient's system for efficacy purposes and to avoid development of resistance (for example a patient with MRSA infection), but not necessarily for 'toxicity'. The exception to this would be patients on aggressive dosing or patients with impaired or unstable renal function, the articles I've read say that these patients should be monitored more closely. I feel like this could go either way and that in some cases (ex. an otherwise healthy patient without renal impairment) it would be a stretch to classify it as high risk. Would you classify IV Vancomycin as high risk?